Ушбу иш иқтибос қилган ишлар

33 та иш

Иш: Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: Systematic review with meta-synthesis of quantitative and qualitative data
Genevieve Coorey, Lis Neubeck, John C. Mulley +1
Шарҳ мақола20182 иқтибос
ABI
Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality
Robin Mathews, William Wang, Lisa A. Kaltenbach +5
Мақола20182 иқтибос
ABI
Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design
Aristi Boulmpou, Αναστάσιος Κάρτας, Ioannis T. Farmakis +9
Мақола20182 иқтибос
ABI
Predictors of all‐cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry
Xavier Rosselló, Héctor Bueno, Stuart Pocock +5
Мақола20182 иқтибос
ABI
Low-density lipoprotein cholesterol target value attainment based on 2019 ESC/EAS guidelines and lipid-lowering therapy titration for patients with acute coronary syndrome
Ioannis T. Farmakis, Stefanos Zafeiropoulos, Areti Pagiantza +9
Мақола20192 иқтибос
ABI
Risk for Recurrent Cardiovascular Events and Expected Risk Reduction With Optimal Treatment 1 Year After an Acute Coronary Syndrome
Stefanos Zafeiropoulos, Ioannis T. Farmakis, Αναστάσιος Κάρτας +15
Мақола20202 иқтибос
ABI
Effect of Patient Financial Incentives on Statin Adherence and Lipid Control
Iwan Barankay, Peter P. Reese, Mary Putt +11
Мақола20202 иқтибос
ABI
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
Kausik K. Ray, Bart Molemans, W. Marieke Schoonen +28
Мақола20202 иқтибос
ABI